Founder and CSO
NT
Neurasic Therapeutics Inc
The startup develops medicinal drugs that target acid-sensing ion channels to treat neurological disorders, eliminating the reliance on opiate-based medications. By blocking these channels, the company provides clinicians with an effective alternative for managing multiple neurological conditions.
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$2.6MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops medicinal drugs that target acid-sensing ion channels to treat neurological disorders, eliminating the reliance on opiate-based medications. By blocking these channels, the company provides clinicians with an effective alternative for managing multiple neurological conditions.